NPTH NeuPath Health Inc.

0.3252USD0.4650 CAD · TSXV-1.06%Mkt Cap: 18.53M USDP/E: 23.25

NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, m…

Insiders, last 90 days25 buys

Key Statistics

Company
Market Cap18.53M USD
Enterprise Value25.05M USD
Revenue (TTM)62.40M USD
Gross Profit11.60M USD
Net Income (TTM)-501.38K USD
Revenue/Share1.11 USD
Last Price0.3252 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees152
CountryCA
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)23.25
P/E (Forward)4.65
PEG—
EV/EBITDA10.01
EV/Revenue0.40
P/S0.30
P/B1.15
EPS (TTM)0.01 USD
EPS (Forward)0.07 USD
52W Range
0.244735% of range0.4755
52W High0.4755 USD
52W Low0.2447 USD
Profitability
Gross Margin19.03%
Oper. Margin2.88%
EBITDA Margin4.01%
Profit Margin-0.82%
ROE-3.48%
ROA-1.59%
ROIC6.87%
ROCE6.30%
Growth
Revenue Growth1.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.80M USD
CapEx (TTM)603.48K USD
FCF Margin1.29%
FCF Yield4.36%
Net Debt6.17M USD
Net Debt/EBITDA2.46
Net Debt/FCF7.64
Balance Sheet
Debt/Equity0.64
Current Ratio1.16
Quick Ratio1.10
Book Value/Sh0.28 USD
Cash/Share0.05 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 6, 2020
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)0.5699 USD
Upside (mean)+75.3%
Target Range0.4755 USD – 0.6643 USD
0.4755+75.3% to mean0.6643
# Analysts2
Ownership
Shares Out.56.98M
Float48.89M
Insiders2.89%
Institutions10.87%
Short Interest
Short Ratio0.1d
Short % Out.0.01%
Shares Short8.35K
Short (prev mo.)4.58K
Technical
SMA 500.3831 (-15.1%)
SMA 2000.3875 (-16.1%)
Beta0.83
S&P 52W Chg8.68%
Avg Vol (30d)71.07K
Avg Vol (10d)55.97K
Technical Indicators
RSI (14)29.6
MACD-0.0187
MACD Signal-0.0109
MACD Hist.-0.0078
BB Upper0.4073 USD
BB Middle0.3706 USD
BB Lower0.3340 USD
BB Width19.78%
ATR (14)0.0172 USD
Vol Ratio (20d)0.21x

About NeuPath Health (CVE: NPTH)

›

NeuPath Health (CVE: NPTH) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 152 employees.

The shares were at 0.4650 CAD on 20 November 2026, up 32.9% over 52 weeks. Its 52-week range is 0.3500 CAD to 0.6800 CAD: the price is 31.6% below the high and 32.9% above the low.

At a market capitalisation of 26.50M CAD, it trades at 23.3 times trailing earnings and 4.7 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 23.8, so NPTH is valued in line with them.

NeuPath Health reports return on equity of -3.5%, an operating margin of 2.9% and revenue up 1.2% year over year.

Its debt exceeds its cash by 8.82M CAD, a debt-to-equity ratio of 0.64. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 2 analysts cover the stock, with an average rating of Buy; their mean price target of 0.8150 CAD is 75.3% above the current price. The next earnings report is expected on 25 March 2027.